2018
DOI: 10.3390/molecules23082071
|View full text |Cite
|
Sign up to set email alerts
|

Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth

Abstract: The anticancer activity of immune checkpoint inhibitors is attracting attention in various clinical sites. Since green tea catechin has cancer-preventive activity in humans, whether green tea catechin supports the role of immune checkpoint inhibitors was studied. We here report that (−)-epigallocatechin gallate (EGCG) inhibited programmed cell death ligand 1 (PD-L1) expression in non–small-cell lung cancer cells, induced by both interferon (IFN)-γ and epidermal growth factor (EGF). The mRNA and protein levels … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
76
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 109 publications
(77 citation statements)
references
References 31 publications
(49 reference statements)
1
76
0
Order By: Relevance
“…In particular, catechins can selectively kill cancer cells by promoting ROS generation over a critical threshold and by mobilization of endogenous chromatin-bound copper ions [30]. Among catechins, EGCG from green tea is one of the most studied, and it has been reported to be active against many types of cancer, including colorectal [31], lung [32], breast [33] and liver [34]. These effects basically arise from its abilities to promote pro-apoptotic effects, inhibit angiogenesis, regulate cellular metabolic pathways, and reduce inflammatory factors [28,35].…”
Section: Discussionmentioning
confidence: 99%
“…In particular, catechins can selectively kill cancer cells by promoting ROS generation over a critical threshold and by mobilization of endogenous chromatin-bound copper ions [30]. Among catechins, EGCG from green tea is one of the most studied, and it has been reported to be active against many types of cancer, including colorectal [31], lung [32], breast [33] and liver [34]. These effects basically arise from its abilities to promote pro-apoptotic effects, inhibit angiogenesis, regulate cellular metabolic pathways, and reduce inflammatory factors [28,35].…”
Section: Discussionmentioning
confidence: 99%
“…In addition to anti-cancer effects, EGCG shows a significant inhibitory effect on interferon-γ (IFN-γ)-induced indoleamine 2,3-dioxygenase (IDO) expression, an enzyme that guides cancer to regulate immune response, in human colorectal cancer SW-837 cells [108], so this suggests that EGCG might be useful for chemoprevention and colorectal cancer treatment, and could be a potential agent for anti-tumor immunotherapy. EGCG is also found to be a potential immune checkpoint inhibitor, which down-regulates IFN-γ-induced B7 homolog 1 (B7-H1) levels, an immunoglobulin-like immune suppressive molecule, in human NSCLC A549 cells [109].…”
Section: Epigallocatechin Gallate (Egcg)mentioning
confidence: 99%
“…EGCG has additionally shown synergistic activity with other anti-cancer treatments, such as tamoxifen (hormone therapy) and nonsteroidal anti-inflammatory drugs (NSAIDs, i.e., cyclooxygenase-2 (COX-2) inhibitors) [145]. EGCG and whole green tea extract also acted as immune checkpoint inhibitors by decreasing the expression of PDL-1 on alveolar adenocarcinoma cell lines and in in vivo murine lung cancer models [146]. It is known that EGCG affects signalling pathways involved in proliferation and apoptosis and is able to inhibit nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathways and other molecular targets involved in the progression of cancer [119,147].…”
Section: Egcgmentioning
confidence: 99%